Attainment of low-density lipoprotein cholesterol target in patients with coronary heart disease: Still a long way to go

Abstract

Get full access to this article

View all access options for this article.

References

World Health Organization. Cardiovascular diseases (CVDs) fact sheet no 317, Geneva, 18 May 2017. www.who.int/mediacentre/factsheets/fs317/en (2017, accessed December 2017).

Ohira

Iso

. Cardiovascular disease epidemiology in Asia: An overview. Circ J 2013; 77: 1646–1652.

Reiner

Catapano

De Backer

et al.

European Association for Cardiovascular Prevention and Rehabilitation. ESC/EAS guidelines for the management of dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2011; 32: 1769–1818.

Catapano

Graham

De Backer

et al.

2016 ESC/EAS guidelines for the management of dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) developed with the special contribution of the European Association for Cardiovascular Prevention and Rehabilitation (EACPR). Eur Heart J 2016; 37: 2999–3058.

Gitt

Drexel

Feely

et al.

(on behalf of the DYSIS Investigators). Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada. Eur J Prev Cardiol 2011; 19: 221–230.

Gitt

Lautsch

Ferrieres

et al.

Low-density lipoprotein cholesterol in a global cohort of 57,885 statin-treated patients. Atherosclerosis 2016; 255: 200–209.

Kotseva

Wood

De Bacquer

et al.

on behalf of the EUROASPIRE Investigators. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from twenty-four European countries. Eur J Prev Cardiol 2016; 23: 636–648.

Zhao

Cooney

Klipstein-Grobusch

et al.

Simplifying the audit of risk factor recording and control: A report from an international study in 11 countries. Eur J Prev Cardiol 2016; 23: 1202–1210.

Ferrari

Ford

Greenaw

et al.

on behalf of the CLARIFY Registry Investigators. Geographical variations in the prevalence and management of cardiovascular risk factors in outpatients with CAD: Data from the contemporary CLARIFY registry. Eur J Prev Cardiol 2015; 22: 1056–1065.

10.

Park

Chiang

Munawar

et al.

Lipid-lowering treatment in hypercholesterolaemic patients: The CEPHEUS Pan-Asian survey. Eur J Prev Cardiol 2012; 19: 781–794.

11.

De Smedt D, De Bacquer D, De Sutter J, et al. The gender gap in risk factor control: Effects of age and education on the control of cardiovascular risk factors in male and female coronary patients. The EUROASPIRE IV study by the European Society of Cardiology. Int J Cardiology 2016; 209: 284–290.

12.

Poh

Ambegaokar

Baxter

et al.

Low-density lipoprotein cholesterol target attainment in patients with stable or acute coronary heart disease in the Asia-Pacific region: Results from the Dyslipidemia International Study II. Eur J Prev Cardiol. 2018; 25: 1950–1963.